Janus Henderson Biotech Innovation Fund II Ltd research brief
CIK 2034032
Generated Nov. 18, 2026, 1:40 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: GRAND CAYMAN Cayman Islands. Reported legal jurisdiction: CAYMAN ISLANDS. These do not establish investor residence or where funds were deployed.
- Aug. 18, 2025 · D/A · 0002034032-25-000002 · Source evidence
Reported offering amount: Unavailable USD. Reported amount sold: 402000000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Janus Henderson Biotech Innovation Fund II Ltd research brief,” CIK 2034032, retrieved Nov. 18, 2026, 1:40 a.m.. Cite the specific accessions used. No amounts have been summed.